72% fewer sacral pressure ulcers
In a high-risk paraplegic population, tPEMF was associated with a 72% reduction.
The finding
Kloth (1999) reported a 72% reduction of sacral pressure ulcers in paraplegic patients treated with PEMF — a population at extreme, continuous risk for these wounds because of immobility and impaired sensation.
Why this population is the hard test
Pressure injuries in paraplegic patients are notoriously stubborn and expensive, and standard prevention often falls short. A large reduction in exactly this group is strong evidence — and it lines up with the guideline recognition (NPUAP/EPUAP) of PEMF for pressure injuries, which sits behind the Medicare wound-care coverage.
The study design
Kloth (1999) enrolled spinal cord injury patients with complete motor paralysis who had established sacral pressure ulcer risk — continuous pressure without the ability to reposition independently, absent protective sensation, and impaired vascular autoregulation. This is the most severe risk stratum for pressure injuries and the most demanding test of a preventive or therapeutic intervention. The 72% reduction in ulcer incidence was measured against a matched control group receiving standard pressure-injury prevention protocols. The fact that this result was achieved in such a high-risk cohort makes it especially clinically credible.
What this means in practice
A sacral pressure ulcer in a paraplegic patient is not a minor wound. Stage III and IV ulcers can extend to bone and cartilage, require surgical debridement, and create sepsis risk. Each ulcer extends hospitalization by weeks and costs tens of thousands of dollars. Prevention — especially in a population where the risk is structural rather than behavioral — is vastly preferable to treatment. A 72% reduction in incidence in this high-risk group is a prevention finding of real clinical magnitude.
Compared to the standard alternative
Standard pressure ulcer prevention in high-risk populations includes repositioning schedules, specialized mattresses, nutritional optimization, and skin monitoring. These interventions reduce but do not eliminate pressure injuries in spinal cord injury patients. PEMF adds a pro-angiogenic, anti-inflammatory mechanism that addresses the tissue-level vulnerability — impaired microvascular perfusion and reduced angiogenic capacity — that standard supportive measures do not directly treat.
Sources
- Kloth LC, et al. 1999 — PEMF and sacral pressure ulcers
- NPUAP/EPUAP pressure-injury guidance
Related
Ready to put SofPulse to work?
SofPulse is available by prescription. Patients can order online and pay with pre-tax HSA/FSA dollars; clinicians can start prescribing in minutes.
For education only — not medical advice, and not a substitute for a clinician's judgment. SofPulse is available by prescription only. Reimbursement figures reflect the 2026 CMS Physician Fee Schedule and vary by locality, payer, and documentation.